On July 18, 2022, the third anniversary celebration of Suzhou Linaxin Biotechnology Co., Ltd. and the first half of 2022 work conference were successfully held in Kunshan! All personnel of the company gather together to look back on the three-year struggle and look forward to the new future of the company!

      At the meeting, Dr. Liu Quanjun, Chief Technology Officer of Linaxin Biotechnology, met with everyone online and affirmed the company's three-year development achievements, while also placing new expectations on the employees.

      Subsequently, an employee signature ceremony was held, leaving the imprint of every Linaxin person on the scroll of "Science and Technology for the Country".

      At the meeting, employees from subsidiary companies and various departments of the group summarized their work for the second quarter and provided an outlook for the next steps of work. Looking back at the first half of 2022, the company's product range has been continuously enriched, and the product packaging has been upgraded; Market online and offline layout, new breakthroughs in production capacity in Shandong production base, and continuous optimization of production management processes;

      Mr. Zhu Wanjie, Deputy General Manager of the company, commented on the work reports of various departments from technology research and development, product optimization to market expansion and internal management, and deployed the operational work arrangements for the second half of the year.

      At the end of the meeting, Dr. Tan Shengwei, the founder of the company, made a summary of the meeting and issued a letter of appointment to the newly appointed expert consultant of the company.

      With dreams and determination, Linaxin Biotechnology has always been committed to the development of the home health self inspection industry. We believe that every Linaxin person can continue to move forward bravely in their future work and contribute their own strength to the innovative and leapfrog development of the pharmaceutical and health industry.